personalized treatments

Invitae launches personalized blood tests to spot cancer relapse

The company’s Personalized Cancer Monitoring platform includes a set of assays that are tailored to a patient’s particular tumor.

Conor Hale Mar 17, 2022 10:20am

Vineti nets $35M to expand logistics software for cell therapy

Feb 6, 2020 9:18am

Pact Pharma launches a trial of its CAR-T for solid tumors

Jul 22, 2019 9:20am

AZ's Baselga on tailored treatments and the march to cure cancer

Jun 4, 2019 11:10am

Personalizing Crohn’s therapies with microRNA as marker

Oct 4, 2018 9:00am

Gritstone Oncology files for $80M IPO

Aug 23, 2018 1:35pm